Life Expectancy Rises Among Type 1 Diabetes Patients

Article

Life expectancy is rising rapidly among patients with type 1 diabetes thanks to new advances in medicine.

Life expectancy of patients with type 1 diabetes has improved dramatically since 1950, results from the long-term, prospective Pittsburgh Epidemiology of Diabetes Complications (EDC) Study show. Dr. Trevor Orchard discusses the study.

Related Videos
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
© 2024 MJH Life Sciences

All rights reserved.